Changes in fasting patterns during Ramadan, and associated clinical outcomes in adults with type 2 diabetes: A narrative review of epidemiological studies over the last 20 years

Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: the observational ORION study

(2020) Mohamed Hassanein et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Managing People with Diabetes Fasting for Ramadan During the COVID‐19 Pandemic: A South Asian Health Foundation Update

(2020) S. Hanif et al.   DIABETIC MEDICINE

The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM)

(2019) Mohamed Hassanein et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Attitude and safety of patients with diabetes observing the Ramadan fast

(2019) Ebtesam M. Ba-Essa et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment

(2019) Viswanathan Mohan et al.   Diabetes Therapy

The effects of Ramadan fasting on activity and energy expenditure

(2018) Nader Lessan et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Health Effects of Overweight and Obesity in 195 Countries over 25 Years

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors

(2017) Ghada M. A. Ajabnoor et al.   PLoS One

Guidelines for managing diabetes in Ramadan

(2016) S. Ali et al.   DIABETIC MEDICINE

Options for Controlling Type 2 Diabetes during Ramadan

(2016) Mussa H. Almalki et al.   Frontiers in Endocrinology

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

(2015) M. C. Riddle et al.   DIABETES OBESITY & METABOLISM

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

(2015) G. B. Bolli et al.   DIABETES OBESITY & METABOLISM

Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED)

(2015) S. M. Babineaux et al.   DIABETIC MEDICINE

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

(2014) Hannele Yki-Järvinen et al.   DIABETES CARE

Having diabetes and having to fast: a qualitative study of British Muslims with diabetes

(2014) Neesha R. Patel et al.   HEALTH EXPECTATIONS

Reduced Risk of Hypoglycemia with Insulin Degludec Versus Insulin Glargine in Patients with Type 2 Diabetes Requiring High Doses of Basal Insulin: A Meta-Analysis of 5 Randomized Begin Trials

(2013) Helena Rodbard et al.   Endocrine Practice

Correction: Relative Metabolic Stability, but Disrupted Circadian Cortisol Secretion during the Fasting Month of Ramadan

(2013) Suhad Bahijri et al.   PLoS One

Recommendations for Management of Diabetes During Ramadan: Update 2010

(2010) M. Al-Arouj et al.   DIABETES CARE

Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan

(2010) V. Bravis et al.   DIABETIC MEDICINE

Adjusting the basal insulin regimen of patients with type 1 diabetes mellitus receiving insulin pump therapy during the Ramadan fast: A case series in adolescents and adults

(2009) Yousra M.A. Hawli et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL